AdaptHealth Corp. (NASDAQ:AHCO) Shares Acquired by Reinhart Partners LLC.

Reinhart Partners LLC. raised its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 1.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,266,854 shares of the company's stock after purchasing an additional 68,212 shares during the quarter. AdaptHealth accounts for approximately 2.3% of Reinhart Partners LLC.'s investment portfolio, making the stock its 19th largest holding. Reinhart Partners LLC. owned approximately 4.66% of AdaptHealth worth $59,660,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. Canada Pension Plan Investment Board purchased a new stake in shares of AdaptHealth in the 2nd quarter worth $58,000. Quarry LP lifted its stake in AdaptHealth by 4,596.9% in the third quarter. Quarry LP now owns 5,965 shares of the company's stock worth $67,000 after acquiring an additional 5,838 shares during the period. Quest Partners LLC grew its holdings in AdaptHealth by 11,522.7% during the 2nd quarter. Quest Partners LLC now owns 10,228 shares of the company's stock worth $102,000 after acquiring an additional 10,140 shares in the last quarter. Johnson Investment Counsel Inc. purchased a new position in AdaptHealth during the 2nd quarter valued at about $115,000. Finally, CIBC Asset Management Inc bought a new stake in shares of AdaptHealth in the 3rd quarter valued at about $122,000. 82.67% of the stock is owned by hedge funds and other institutional investors.

AdaptHealth Stock Performance

NASDAQ:AHCO traded up $0.19 during trading hours on Monday, hitting $10.33. 870,691 shares of the company were exchanged, compared to its average volume of 778,942. The company's 50 day moving average price is $9.86 and its 200-day moving average price is $10.34. The stock has a market capitalization of $1.39 billion, a price-to-earnings ratio of -6.26, a PEG ratio of 1.34 and a beta of 1.09. AdaptHealth Corp. has a 52-week low of $6.46 and a 52-week high of $11.90. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00.

AdaptHealth (NASDAQ:AHCO - Get Free Report) last released its earnings results on Tuesday, November 5th. The company reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.02). The firm had revenue of $805.90 million during the quarter, compared to analyst estimates of $809.32 million. AdaptHealth had a negative net margin of 6.57% and a positive return on equity of 9.62%. AdaptHealth's revenue was up .2% on a year-over-year basis. During the same period in the previous year, the company earned $0.19 earnings per share. As a group, research analysts forecast that AdaptHealth Corp. will post 0.88 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on AHCO. Robert W. Baird dropped their price objective on shares of AdaptHealth from $16.00 to $14.00 and set an "outperform" rating on the stock in a research note on Wednesday, November 6th. Royal Bank of Canada decreased their price objective on AdaptHealth from $13.00 to $11.00 and set an "outperform" rating for the company in a research note on Tuesday, November 19th. Truist Financial reduced their target price on shares of AdaptHealth from $13.00 to $12.00 and set a "buy" rating for the company in a report on Friday, November 15th. UBS Group lowered their price target on shares of AdaptHealth from $13.00 to $12.00 and set a "buy" rating on the stock in a report on Wednesday, November 6th. Finally, Canaccord Genuity Group reduced their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research note on Wednesday, November 6th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $12.40.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.